CHE

NEUTRALEarnings

Chemed Corp

2026-08-12

Price

$541.02

+0.72%

This is the 2026-08-12 snapshot — the signals and analysis for CHE as of this single trading day.

View full CHE research hub →

Score3.0Watchlist

Signals2/8 DNA0/13 Act · 0/4 Risk

SentimentNEUTRALScore: 8

Volume0.7xvs 20d avg

Analysis

Chemed Corp (CHE) is surging through price discovery, propelled by a blowout Q2 earnings beat, raised FY2026 guidance, and a massive 17% dividend hike. This fundamental strength perfectly validates the PERFECT_STACK and GOLDEN_CROSS technical signals, driving a +7.3% relative outperformance versus the SPY as institutional absorption accelerates. Furthermore, the current RISK_ON (RATES) Goldilocks macro backdrop provides the ideal environment for Chemed's defensive yet growing cash flows (VITAS and Roto-Rooter) to command a premium, cementing this as a high-conviction breakout.

Fired Signals

GOLDEN CROSSPERFECT STACK

Key Takeaways

CHE is demonstrating High-Conviction Price Discovery, supported by raised FY26 EPS guidance ($25.00-$25.75) and a recent 17% dividend increase to $0.70 per share.
The primary risk stems from potential macroeconomic softening impacting Roto-Rooter's consumer demand or unexpected adjustments to the Medicare cap for the VITAS segment.
Watch the $501.51 technical line-in-the-sand to confirm the trend's durability, alongside institutional flow following AQR Capital's newly disclosed 7.25% stake.

← Back to 2026-08-12 View Full CHE History →Yahoo Finance &nearr;